| 000 | 01869 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518073520.0 | ||
| 264 | 0 | _c20200908 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.19.01892 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrey, Noelle V | |
| 245 | 0 | 0 |
_aOptimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c02 2020 |
||
| 300 |
_a415-422 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xtherapy |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aShaw, Pamela A | |
| 700 | 1 | _aHexner, Elizabeth O | |
| 700 | 1 | _aPequignot, Edward | |
| 700 | 1 | _aGill, Saar | |
| 700 | 1 | _aLuger, Selina M | |
| 700 | 1 | _aMangan, James K | |
| 700 | 1 | _aLoren, Alison W | |
| 700 | 1 | _aPerl, Alexander E | |
| 700 | 1 | _aMaude, Shannon L | |
| 700 | 1 | _aGrupp, Stephan A | |
| 700 | 1 | _aShah, Nirav N | |
| 700 | 1 | _aGilmore, Joan | |
| 700 | 1 | _aLacey, Simon F | |
| 700 | 1 | _aMelenhorst, Jos J | |
| 700 | 1 | _aLevine, Bruce L | |
| 700 | 1 | _aJune, Carl H | |
| 700 | 1 | _aPorter, David L | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 38 _gno. 5 _gp. 415-422 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.19.01892 _zAvailable from publisher's website |
| 999 |
_c30399501 _d30399501 |
||